Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Yurgin

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Current Medical Research and Opinion|July 27, 2007
Obese versus non-obese patients with type 2 diabetes: patient-reported outcomes and utility of weight changeLouis S Matza, Nicole Yurgin, Kristina S Boye, et al.
Applied Health Economics and Health Policy|July 23, 2013
Cost effectiveness of denosumab versus oral bisphosphonates for postmenopausal osteoporosis in the USAnju Parthan, Morgan Kruse, Nicole Yurgin, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|September 27, 2013
Development and preliminary validation of a Function IndeX for Trauma (FIX-IT)Mohit Bhandari, Scott M Wasserman, Nicole Yurgin, et al.
Journal of the American Heart Association|May 8, 2016
Cost-Effectiveness of Ivabradine for Heart Failure in the United StatesAnuraag R Kansal, Martin R Cowie, Adrian Kielhorn, et al.
Current Medical Research and Opinion|November 7, 2017
Real-world cardiovascular disease burden in patients with atherosclerotic cardiovascular disease: a comprehensive systematic literature reviewDasha Cherepanov, Tanya G K Bentley, Wendy Hsiao, et al.
Pharmacological Research|May 6, 2008
Prevalence and antihyperglycemic prescribing trends for patients with type 2 diabetes in Italy: a 4-year retrospective study from national primary care dataGiampiero Mazzaglia, Nicole Yurgin, Kristina S Boye, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 20, 2007
Utilities and disutilities for type 2 diabetes treatment-related attributesLouis S Matza, Kristina S Boye, Nicole Yurgin, et al.
Current Medical Research and Opinion|March 16, 2007
Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomesJoshua A Ray, Kristina S Boye, Nicole Yurgin, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Current Medical Research and Opinion|July 27, 2007
Obese versus non-obese patients with type 2 diabetes: patient-reported outcomes and utility of weight changeLouis S Matza, Nicole Yurgin, Kristina S Boye, et al.
Applied Health Economics and Health Policy|July 23, 2013
Cost effectiveness of denosumab versus oral bisphosphonates for postmenopausal osteoporosis in the USAnju Parthan, Morgan Kruse, Nicole Yurgin, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|September 27, 2013
Development and preliminary validation of a Function IndeX for Trauma (FIX-IT)Mohit Bhandari, Scott M Wasserman, Nicole Yurgin, et al.
Journal of the American Heart Association|May 8, 2016
Cost-Effectiveness of Ivabradine for Heart Failure in the United StatesAnuraag R Kansal, Martin R Cowie, Adrian Kielhorn, et al.
Current Medical Research and Opinion|November 7, 2017
Real-world cardiovascular disease burden in patients with atherosclerotic cardiovascular disease: a comprehensive systematic literature reviewDasha Cherepanov, Tanya G K Bentley, Wendy Hsiao, et al.
Pharmacological Research|May 6, 2008
Prevalence and antihyperglycemic prescribing trends for patients with type 2 diabetes in Italy: a 4-year retrospective study from national primary care dataGiampiero Mazzaglia, Nicole Yurgin, Kristina S Boye, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 20, 2007
Utilities and disutilities for type 2 diabetes treatment-related attributesLouis S Matza, Kristina S Boye, Nicole Yurgin, et al.
Current Medical Research and Opinion|March 16, 2007
Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomesJoshua A Ray, Kristina S Boye, Nicole Yurgin, et al.
Pageof 2